Troy Shields, MD
Sports Medicine · Reno, NVNPI 1285011007
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $26,169 with a category attached, or 76.4%. Arthrex accounts for 76.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $22,000 and has fallen 99.6% since, to $84 in 2025.
Across 37 payments — averaging $707.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Smith+Nephew$4K
- Stryker$2K
- Vericel Corporation$192
- Vertex$84
- Evolution Surgical, Inc$53
- plus $198 from 9 others
What the payments were for
- Grants$20,00076%
- Travel & lodging$5572%
- Food & beverage$1,6126%
- Education$4,00015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $20,000 |
| Smith+Nephew | 5 | $4,056 |
| Stryker | 12 | $1,585 |
| Vericel Corporation | 5 | $192 |
| Vertex | 1 | $84 |
| Evolution Surgical, Inc | 2 | $53 |
| Relievant Medsystems, Inc. | 3 | $36 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| KCI USA, Inc. | 1 | $24 |
| Medtronic | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Organogenesis Inc. | 1 | $20 |
| Heraeus Medical, LLC. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,169 in reported general payments places this provider in the 85th percentile of 49 sports medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 92 | $1,871 |
| Oxycodone Hcl | 51 | $372 |
| Amoxicillin | 18 | $22 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Reno
- Brian GilmerReno$204K
- Daniel CurtisReno$42K
- Alex LencioniReno$41K
- Renny UppalReno$6K
- Meagan McCarthyReno$4K
- Michael KalisvaartReno$800
- Tori EdmistonReno$361
- Mark StovakReno$171
- Phillip ZinniReno$118
- Ryan DobbsReno$106
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.